Nicholas Naclerio

Nicholas J.
Naclerio was the founder of Quanterix Corp., founded in 2007, where the title held was Chairman & Chief Executive Officer from 2007 to 2009.
Dr. Naclerio is the founder of IIF Management Co. LLC, founded in 2015, holding the title of Founding Partner since 2016.
Current jobs include Chairman at Stilla Technologies SA since 2018; Director at Baebies, Inc.; Director at Serimmune, Inc. since 2016; Director at Genome Medical, Inc.; Director at DNA Script SAS; Director at Pattern Bioscience, Inc.; Director at Alamar Biosciences, Inc. (California) since 2020; Director at Alamar Biosciences, Inc. since 2020; Board Member at Biota Technology, Inc. since 2017; Board Member at LetsGetChecked, Inc. since 2020; and Board Member at Cradle Genomics, Inc. since 2019.
Former jobs include President & Chief Executive Officer at ParAllele BioScience, Inc. from 2003 to 2005; Executive Chairman at True Materials, Inc. in 2008; Director at SEMATECH, Inc.; Director at Orchid Cellmark, Inc.; Director at Genometrix, Inc.; Director at Boreal Genomics, Inc.; Director at Clinical Micro Sensors, Inc.; Director at The SNP Consortium Ltd.; Director at Twin Lights Bioscience, Inc. from 2009 to 2012;.
Senior VP-Corporate & Venture Development at Illumina, Inc.; SVP-Corporate & Venture Development at Illumina, Inc. from 2010 to 2016; Board Observer at Twist Bioscience Corp.
from 2017 to 2018; Chief Business Officer at Zyomyx, Inc.; Principal at US Defense Advanced Research Projects Agency; Vice President & General Manager-Life Sciences at Motorola Corp.; Principal at US Air Force; Board Observer at Chrome Holding Co. from 2010 to 2016.
Education includes undergraduate degree from Duke University, graduate degree from the University of Cambridge conferred in 1984, and doctorate from the University of Maryland.